HY2Care

Geleen, Netherlands · Founded 2014 · Privately Held (backing)

Manufacturer of an injectable hydrogel designed to repair cartilage defects. HY2Care is based in Geleen, Netherlands and was founded in 2014. It has raised $9.2 million.

Last price · $/share
—
Implied valuation
—
Total raised
$9.2M
Last round
—
Valuation — not yet established

No valuation for HY2Care is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($9.2M) and the funding record below are the closest available signals.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of HY2Care with a free account
  • ·Watch HY2Care: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

HY2Care funding history

No rounds on record

No funding rounds for HY2Care are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

How HY2Care's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For HY2Care, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked about HY2Care

How much has HY2Care raised?
HY2Care has raised $9.2M in total funding across its recorded rounds.